Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT05184166
Eligibility Criteria:
Inclusion Criteria:
* age ≥ 70 years on admission to hospital
* diagnosis of SARS-CoV-2 infection defined by a positive RT-PCR test
* medical or critical care hospitalisation between 1 July 2020 and 31 August 2021
* who experienced severe hypoxaemic acute respiratory failure defined as at least 4L/min of oxygen during hospitalisation
Exclusion Criteria:
* Oxygen therapy \< 4L/min during hospitalisation
* Mc Cabe score 3 (chronic disease fatal at 1 year such as stage IV heart failure, ventilated respiratory failure, metastatic cancer, Child C cirrhosis)
* dementia or cognitive disorders before hospitalisation reported in the medical record
* patient GIR 1 to 4 before hospitalisation reported in the medical file or deduced from the description of the lifestyle
* patient with an ADL score \< 4 before hospitalisation reported in the medical record or deduced from the description of lifestyle
* patient living in EHPAD before hospitalisation
* non-French speaking patient
* patient under guardianship or curatorship
* refusal to participate in the study for patients surviving 1 year or refusal by a family member or trusted person
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT05184166
Study Brief:
Protocol Section:
NCT05184166